Healthcare provider profile · identity verified

Rudolph Antoncic

Internal Medicine · PITTSBURGH, PA · NPI 1043282437

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	432	48
Sertraline Hcl	Sertraline Hcl	400	36
Levothyroxine Sodium	Levothyroxine Sodium	297	36
Pantoprazole Sodium	Pantoprazole Sodium	287	45
Amlodipine Besylate	Amlodipine Besylate	274	36
Tamsulosin Hcl	Tamsulosin Hcl	250	22
Furosemide	Furosemide	249	34
Eliquis	Apixaban	244	32
Potassium Chloride	Potassium Chloride	239	30
Gabapentin	Gabapentin	225	22
Lisinopril	Lisinopril	193	29
Quetiapine Fumarate	Quetiapine Fumarate	185	21
Trazodone Hcl	Trazodone Hcl	180	15
Metoprolol Tartrate	Metoprolol Tartrate	147	24
Simvastatin	Simvastatin	124	15
Metformin Hcl	Metformin Hcl	115	14
Losartan Potassium	Losartan Potassium	113	12
Metoprolol Succinate	Metoprolol Succinate	104	19
Olanzapine	Olanzapine	104	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	103	21
Famotidine	Famotidine	101	11
Bumetanide	Bumetanide	100	suppressed
Risperidone	Risperidone	99	11
Fluoxetine Hcl	Fluoxetine Hcl	96	suppressed
Clopidogrel	Clopidogrel Bisulfate	94	16
Prednisone	Prednisone	93	14
Carvedilol	Carvedilol	91	12
Jardiance	Empagliflozin	90	suppressed
Omeprazole	Omeprazole	90	suppressed
Donepezil Hcl	Donepezil Hcl	85	12
Levetiracetam	Levetiracetam	78	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	76	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	76	suppressed
Latanoprost	Latanoprost	70	suppressed
Mirtazapine	Mirtazapine	66	suppressed
Duloxetine Hcl	Duloxetine Hcl	63	suppressed
Bupropion Xl	Bupropion Hcl	61	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	61	suppressed
Oxycodone Hcl	Oxycodone Hcl	55	suppressed
Memantine Hcl	Memantine Hcl	54	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	53	suppressed
Buspirone Hcl	Buspirone Hcl	52	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	51	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	49	suppressed
Topiramate	Topiramate	49	suppressed
Methimazole	Methimazole	48	suppressed
Pravastatin Sodium	Pravastatin Sodium	47	suppressed
Allopurinol	Allopurinol	45	suppressed
Hydralazine Hcl	Hydralazine Hcl	45	suppressed
Valsartan	Valsartan	45	suppressed
Bupropion Hcl	Bupropion Hcl	44	suppressed
Midodrine Hcl	Midodrine Hcl	43	suppressed
Finasteride	Finasteride	42	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	41	suppressed
Clonazepam	Clonazepam	41	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	41	suppressed
Ursodiol	Ursodiol	41	suppressed
Divalproex Sodium	Divalproex Sodium	40	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	39	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	38	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	37	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	37	suppressed
Lorazepam	Lorazepam	36	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	suppressed
Tramadol Hcl	Tramadol Hcl	34	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	33	suppressed
Clonidine Hcl	Clonidine Hcl	33	suppressed
Xarelto	Rivaroxaban	33	suppressed
Nystatin	Nystatin	32	19
Montelukast Sodium	Montelukast Sodium	31	suppressed
Atenolol	Atenolol	30	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	30	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	11
Spironolactone	Spironolactone	29	suppressed
Fluticasone Propionate	Fluticasone Propionate	28	11
Metformin Hcl Er	Metformin Hcl	28	suppressed
Alendronate Sodium	Alendronate Sodium	27	suppressed
Methenamine Hippurate	Methenamine Hippurate	27	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	27	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	suppressed
Dutasteride	Dutasteride	25	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	12
Triamcinolone Acetonide	Triamcinolone Acetonide	25	suppressed
Amiodarone Hcl	Amiodarone Hcl	24	suppressed
Hydrocortisone	Hydrocortisone	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Cefuroxime	Cefuroxime Axetil	22	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Haloperidol	Haloperidol	21	suppressed
Lumigan	Bimatoprost	21	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	21	suppressed
Celecoxib	Celecoxib	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Renvela	Sevelamer Carbonate	19	suppressed
Azithromycin	Azithromycin	18	suppressed
Benztropine Mesylate	Benztropine Mesylate	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Linzess	Linaclotide	17	suppressed
Loperamide	Loperamide Hcl	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Unifine Safecontrol Pen Needle	Pen Needle,dual Safety,diabetc	15	suppressed
Indapamide	Indapamide	14	suppressed
Moxifloxacin	Moxifloxacin Hcl	14	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	suppressed
Tiotropium Bromide	Tiotropium Bromide	13	suppressed
Torsemide	Torsemide	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Baclofen	Baclofen	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Acetazolamide Er	Acetazolamide	11	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Cefepime Hcl	Cefepime Hcl	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Heparin Sodium	Heparin Sodium,porcine	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Movantik	Naloxegol Oxalate	11	suppressed
Ongentys	Opicapone	11	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error